NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION

NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION

Background. Effects of statins on cardiovascular end points are well-known. To study the impact of statins on structural and functional heart remodeling in patients with arterial hypertension (HT) seemsto be topical.Aim. To study the effect of statins on cardiac remodeling in patients with HT.Materi...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	statins arterial hypertension angiotensin ii receptor antagonists heart remodeling
Online Access:	https://www.rpcardio.online/jour/article/view/921
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Angiotensin II type 1 receptor antagonists and their combinations in the treatment of hypertension
by: J.A. Ker
Published: (2012-06-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Statins in arterial hypertension treatment
by: O. N. Tkacheva, et al.
Published: (1970-01-01)

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)

Endothelial functional activity and circadian blood pressure dynamics in hypertensive patients treated with angiotensin receptor antagonists
by: N. G. Poteshkina, et al.
Published: (2011-10-01)

Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01)

EXPERIENCE OF USING THE NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
by: M. A. Simakova, et al.
Published: (2018-04-01)

Overweight and early heart remodelling in women with arterial hypertension
by: E. M. Khurs, et al.
Published: (2010-04-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations
by: T. V. Martynyuk, et al.
Published: (2010-04-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine
by: S. Yu. Martsevich
Published: (2020-05-01)

Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
by: Zhang He-ping, et al.
Published: (2022-04-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities
by: N. G. Pivonova, et al.
Published: (2009-08-01)

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension
by: Wenze Wu, et al.
Published: (2025-08-01)

Estudio del efecto inhibitorio de extractos de Salvia scutellarioides sobre la actividad de la enzima convertidora de angiotensina
by: Gina Méndez-Callejas, et al.
Published: (2009-12-01)

Factor Analysis for Predicting the Structural Reorganization of the Microvasculature of the Kidneys in Patients with Glomerulonephritis and Arterial Hypertension
by: E. S. Levitskaya, et al.
Published: (2024-02-01)

ENALAPRIL MALEATE IN TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS
by: L. I. Katelnitskaya, et al.
Published: (2002-10-01)

CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY
by: R. I. Striuk
Published: (2016-01-01)

AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY
by: V. M. Tsareva, et al.
Published: (2016-01-01)

Psychosomatic status parameters and cardiovascular remodeling in patients with arterial hypertension
by: A. V. Shabalin, et al.
Published: (2005-04-01)

ML enhanced bioactivity prediction for angiotensin II receptor: A potential anti-hypertensive drug target
by: Jeyanthi Sankar, et al.
Published: (2025-07-01)

INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. R. Veber, et al.
Published: (2016-01-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01)

PREDICTION ROLE OF THE LEFT VENTRICLE REMODELLING IN ARTERIAL HYPERTENSION PATIENTS
by: S. V. Ivanova, et al.
Published: (2016-12-01)

IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Parathyroid function and cardiovascular remodeling in arterial hypertension patients
by: B. G. Iskenderov, et al.
Published: (2008-04-01)

VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL
by: Yu. N. Belenkov, et al.
Published: (2012-06-01)

Heart pathology in patients with arterial hypertension and metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

Combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients with arterial hypertension and coronary heart disease: efficacy and safety
by: B. G. Iskanderov, et al.
Published: (2005-12-01)

Role of the individual metabolic syndrome components and heart remodelling progression in women
by: E. M. Khurs, et al.
Published: (1970-01-01)

REMODELING OF CEREBRAL ARTERIES IN DYSCIRCULATORY ENCEPHALOPATHY WITH ARTERIAL HYPERTENSION AND STROKE IN PATIENTS WITH RADIATION ANAMNESIS
by: G. G. Efremushkin, et al.
Published: (2016-04-01)

Left ventricular remodelling types in elderly patients with arterial hypertension
by: L. Kh. Gadzhieva, et al.
Published: (2013-02-01)